Blue Steens newsletter icon

Check out my latest monthly review! It showcases Blue Steens’ latest posts, some news from biopharma & medtech as well as interesting events I have attended or noticed.

At a glance

In terms of COVID-19, more interesting new test kits have emerged; remdesivir gained FDA approval, yet trial interpretations are still a mixed bag; and vaccine development remains a global roller coaster. October has also seen the first approved Ebola treatment, which is an antibody cocktail. Another cool story revolves around using ultra-sound for targeted drug delivery.

Replays to a few virtual events can be found at the end. I keep adding my favourite replays and other relevant videos to my nascent blockchain playlist on YouTube.

Click to read >>>